ImmuPharma (LON:IMM) Trading Up 12.5% – Here’s What Happened

ImmuPharma plc (LON:IMM) rose 12.5% during trading on Friday . The company traded as high as GBX 5.80 ($0.07) and last traded at GBX 5.50 ($0.07). Approximately 19,527,068 shares changed hands during trading, a decline of 23% from the average daily volume of 25,520,734 shares. The stock had previously closed at GBX 4.89 ($0.06).

ImmuPharma Trading Up 10.6 %

The company has a market cap of £24.86 million, a P/E ratio of -597.00 and a beta of 1.53. The business’s 50 day simple moving average is GBX 2.06 and its 200 day simple moving average is GBX 1.83.

ImmuPharma Company Profile

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.